These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24114249)

  • 21. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.
    Imberti D; Gallerani M; Manfredini R
    J Thromb Thrombolysis; 2012 Aug; 34(2):208-13. PubMed ID: 22466929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M; Sobieraj DM
    Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.
    Kim S; Ahn H; Shin SA; Park JH; Won CW
    Thromb Res; 2017 Jul; 155():48-52. PubMed ID: 28486159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Falck-Ytter Y; Francis CW; Johanson NA; Curley C; Dahl OE; Schulman S; Ortel TL; Pauker SG; Colwell CW
    Chest; 2012 Feb; 141(2 Suppl):e278S-e325S. PubMed ID: 22315265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
    Burness CB; McKeage K
    Drugs; 2012 May; 72(7):963-86. PubMed ID: 22564134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Prospective Cohort Comparative Study of Rivaroxaban, Dabigatran, and Apixaban Oral Thromboprophylaxis in 2431 Hip and Knee Arthroplasty Patients: Primary Efficacy Outcomes and Safety Profile.
    Highcock AJ; As-Sultany M; Finley R; Donnachie NJ
    J Arthroplasty; 2020 Nov; 35(11):3093-3098. PubMed ID: 32674939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolic disease in patients with haemophilia.
    Hermans C
    Thromb Res; 2012 Oct; 130 Suppl 1():S50-2. PubMed ID: 23026662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].
    Gómez Arrayas I; Suárez Fernández C; Gómez Cerezo JF; Betegón Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Salud Publica; 2012 Dec; 86(6):601-12. PubMed ID: 23325135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery.
    Rostagno C
    Cardiovasc Hematol Disord Drug Targets; 2016; 15(3):204-9. PubMed ID: 26721520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
    Runner RP; Shau DN; Staley CA; Roberson JR
    J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.
    Lassen MR
    Drugs Today (Barc); 2012 Apr; 48(4):249-58. PubMed ID: 22536567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
    Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
    J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
    Mrozik D; Jackiewicz A; Krzemiński M
    Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative antithrombotic management in joint replacement surgeries.
    Lee HL; Chiu KY; Yiu KH; Ng FY; Yan CH; Chan PK
    Hong Kong Med J; 2013 Dec; 19(6):531-8. PubMed ID: 24141860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities for improvement: anticoagulation in patients undergoing total knee or hip replacement.
    Thorsberger M; Jensen T; Olesen J; Weeke P; Wahlsten L; Jensen P; Gislason G; Torp-Pedersen C; Koeber L; Fosbøl E
    J Orthop Sci; 2015 Nov; 20(6):1036-45. PubMed ID: 26293801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
    Eriksson BI; Friedman RJ
    Clin Appl Thromb Hemost; 2009; 15 Suppl 1():25S-31S. PubMed ID: 19648146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in the use of oral anticoagulants.
    Lassen MR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1769-81. PubMed ID: 19548861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.